Three herbs you should get to know

American Journal of Nursing

Volumn 101, Issue 4, 2001, Pages 48-53

  Waddell, Donna L ^a   Hummel, M Elaine ^a   Sumners, Ann D ^a  

^a UNIVERSITY OF NORTH GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; HYPNOTIC SEDATIVE AGENT; KAVA;

ANIMAL; ANXIETY; CLINICAL TRIAL; DEMENTIA; DEPRESSION; GINKGO BILOBA; HUMAN; HYPERICUM; MEDICINAL PLANT; NURSING; PATIENT EDUCATION; PHYTOTHERAPY; REVIEW; UNITED STATES;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; CLINICAL TRIALS; DEMENTIA; DEPRESSION; GINKGO BILOBA; HUMANS; HYPERICUM; HYPNOTICS AND SEDATIVES; KAVA; NURSING; PATIENT EDUCATION; PHYTOTHERAPY; PLANTS, MEDICINAL; UNITED STATES;

EID: 0040620235     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000446-200104000-00022     Document Type: Article

References (24)

1. Johnston B. One-third of nation's adults use herbal remedies. HerbalGram 1997:49.
2. ABC News. The kava craze: the herb that may relieve stress and anxiety; 1998 Jun 22.
3. Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998;158(20):2200-11.
4. Volz HP, Kieser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders - a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry 1997;30(1):1-5.
5. Kinder C, Cupp MJ. Kava: an herbal sedative [letter]. Nurse Pract 1998;23(6):14, 156.
6. Zuess J. The natural Prozac program: how to use St. John's wort, the anti-depressant herb. New York: Three Rivers Press; 1997.
7. Volz HP. Controlled clinical trials of hypericum extracts in depressed patients - an overview. Pharmacopsychiatry 1997;30 Suppl 2:72-6.
8. National Center for Complementary and Alternative Medicine. St. John's wort [online fact sheet]. 2000. http://nccam.nih.gov/nccam/fcp/factsheets/stjohnswort/ stjohnswort.htm.
9. Woelk H, et al. Benefits and risks of the hypericum extract LI 160: drug monitoring study with 3250 patients. J Geriatr Psychiatry Neurol 1994;7 Suppl 1:S34-8.
10. Muller WE, Rossol R. Effects of hypericum extract on the expression of serotonin receptors. J Geriatr Psychiatry Neurol 1994;7 Suppl 1:S63-4.
11. Linde K, et al. St John's wort for depression - an overview and meta-analysis of randomised clinical trials. BMJ 1996;313(7052):253-8.
12. Blumenthal M, et al., editors. The complete German Commission E monographs: therapeutic guide to herbal medicines. Austin (TX): American Botanical Council; 1998.
13. Marsa L. If it's on the shelf, it's safe . . . Right? Good Housekeeping 1998 Apr:112-6.
14. Satyan KS, et al. Anxiolytic activity of ginkgolic acid conjugates from Indian Ginkgo biloba. Psychopharmacology (Berl) 1998;136(2):148-52.
15. Zhu L, et al. Neuron degeneration induced by verapamil and attenuated by EGb761. J Basic Clin Physiol Pharmacol 1997;8(4):301-14.
16. Cohen AJ, Bartlik B. Ginkgo biloba for antidepressant-induced sexual dysfunction. J Sex Marital Ther 1998;24(2):139-43.
17. Oken BS, et al. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 1998;55(11):1409-15.
18. Itil TM, et al. The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine. Psychopharmacol Bull 1998;34(3):391-7.
19. Shadlen MF, Larson EB. What's new in Alzheimer's disease treatment? Reasons for optimism about future pharmacologic options. Postgrad Med 1999;105(1):109-18.
20. Le Bars PL, et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA 1997;278(16):1327-32.
21. Akisu M, et al. Platelet-activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo biloba extract reduce PAF concentration in the brain. Biol Neonate 1998;74(6):439-44.
22. Berg JA, et al. Integrative therapies in primary care practice. J Am Acad Nurse Pract 1998;10(12):541-6.
23. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract [letter]. N Engl J Med 1997;336(15):1108.
24. National Institute of Mental Health. Coordinating center for clinical trial of hypericum perforatum in depressive disorder. NIH Guide 1997 Jun 26:NIMH-97-CR-0007.